FDA Reports Refusals of Shrimp Imports Contaminated with Banned Antibiotics from a Wide Variety of Countries

For the month of October, the U.S. Food and Drug Administration (FDA) reports that 4 out of the 96 (4.2%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics. The FDA additionally updated its reporting for the month of September to now include an additional refusal of a shrimp entry line for reasons related to […]

Filed Under


Indian Shrimp Refusals for Antibiotics This Year Match Record Year for China Shrimp Refusals

The U.S. Food and Drug Administration’s (FDA) recently released information regarding entry line refusals for the month of November.  The cumulative data released by the FDA for 2016 indicates that refusals of entry lines of Indian shrimp for antibiotics is equal to the highest number of entry lines of Chinese shrimp for antibiotics ever reported in a year. Farmed shrimp […]

Filed Under


Southern Shrimp Alliance Statement on Antibiotics in Imported Shrimp

The Southern Shrimp Alliance opposes the use of banned antibiotics in shrimp aquaculture.  Beyond undermining consumer confidence in the wholesomeness of shrimp in the U.S. market, the use of banned antibiotics unethically reduces production costs for farmed shrimp by shifting risks from the producer to the consumer. The Southern Shrimp Alliance has made the continued presence of banned antibiotics in […]

Filed Under


Since February, FDA Has Added Thirteen More Shrimp Exporters, Including BAP-Certified Companies, to Antibiotic Import Alerts

Since the beginning of February, the U.S. Food and Drug Administration (“FDA”) has added thirteen (13) additional shrimp companies to either Import Alerts 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”) or 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”).  The numerous additions to these two Import Alerts follows the heightened number […]

Filed Under